Find Academic Supervisors

Alexandra LusserView profile

Professor

• Chromatin remodeling
• Chromatin assembly
• Epigenetics
• +5 more

Professor Alexandra Lusser serves as Professor and Deputy Head in the Department of Molecular Biology at Innsbruck Medical University, where she leads the Chromatin and Epigenetics Laboratory. Her research focuses on understanding the molecular mechanisms of chromatin assembly, remodeling, and epigenetic regulation at both DNA and RNA levels. Professor Lusser completed her PhD at the University of Innsbruck in 1998, followed by postdoctoral training at the University of California, San Diego (2001-2004) in the laboratory of Professor JT Kadonaga. She joined Innsbruck Medical University as Assistant Professor in 2004, achieved her Habilitation for Molecular Biology in 2008, was promoted to Associate Professor, and became a full Professor in 2019. Her research program investigates how eukaryotic DNA is organized in chromatin and how this organization affects DNA metabolism processes including transcription, replication, repair, and recombination. A significant portion of her work examines ATP-dependent chromatin assembly and remodeling mechanisms, variant histone assembly, and epigenetic mechanisms at the mRNA level, particularly mRNA base modifications such as 5-methylcytosine and their roles in mRNA metabolism and translation. Her publications reveal a strong focus on developing and applying innovative biochemical and genomic techniques to study RNA modifications and chromatin dynamics. Professor Lusser's extensive publication record spanning from 1996 to the present demonstrates consistent contributions to the fields of chromatin biology and RNA epigenetics. Her recent work shows particular emphasis on developing novel sequencing methods for RNA modification analysis, exploring the functional consequences of RNA modifications, and investigating the relationship between chromatin remodeling factors and neurological functions. HOECHST Award (1998) APART 3-year postdoctoral fellowship from the Austrian Academy of Sciences (2001) START Prize from the Ministry of Science and Research (2005) Member of the Young Curia of the Austrian Academy of Sciences (2008-2016) Research Award from the State Capital Innsbruck (2009) As Deputy Head of the Department of Molecular Biology, Professor Lusser contributes to departmental leadership while maintaining an active research program. Her laboratory has developed several important methodologies including TUC-Seq for measuring mRNA transcription and degradation rates, bisulfite sequencing for detecting 5-methylcytosine in RNA, and other innovative approaches for studying RNA modifications. Her work bridges molecular biology, biochemistry, and genomics, with implications for understanding fundamental biological processes and potential applications in disease research.

Metin Hayri AcarView profile

Professor

• Polymer Chemistry
• Materials Science
• Polymerization Techniques
• +3 more

Metin Hayri Acar is a Professor of Chemistry at Istanbul Technical University. His research focuses on polymer chemistry, materials science, and advanced polymerization techniques such as ATRP and RAFT. He leads projects on nanocomposite materials, shape memory polymers, and biomedical applications. His work includes designing polymers for drug delivery, ultrafiltration membranes, and medical imaging technologies. Key projects include 'Obtaining Cheap and Easily Processable Fuel Cell Membrane from Commercial Polymers by Controlled Polymerization' (2014-2021) and 'Phantom Preparation for Microwave Breast Cancer Imaging' (2021-2022). He has published extensively in journals like Journal of Applied Polymer Science and European Polymer Journal . His research interests span copolymer synthesis, nanomaterials, and polymer-based medical solutions. Recent studies include N-alkylation ligand optimization for ATRP (2023), shape-memory PVDF copolymers (2019), and chitosan-based drug formulations for diabetes (2019). His work bridges fundamental polymer science with practical applications in healthcare and engineering. Academic contributions include over 39 research outputs and 3 major funded projects. His articles frequently address polymer morphology, electrochemical properties, and material performance under varying conditions.

• Brain Energy Metabolism
• Magnetic Resonance Imaging (MRI)
• Molecular Imaging
• +5 more

Dr. D. S. Fahmeed Hyder is a Professor of Radiology & Biomedical Imaging and Biomedical Engineering at Yale University, with joint appointments in the Yale School of Medicine. He leads the Magnetic Resonance Research Center (MRRC) and directs the Core Center for Quantitative Neuroscience with Magnetic Resonance (QNMR). His research focuses on brain energy metabolism, developing advanced MRI techniques to study neuronal-glial interactions, metabolic dysfunction biomarkers, and molecular imaging of tumors. He holds over 240 peer-reviewed publications and has secured continuous NIH funding for 25+ years. Education: B.A. in Chemistry (Wabash College, 1990), Ph.D. in Biophysical Chemistry (Yale University, 1995). Postdoctoral training includes roles at Oak Ridge National Laboratory, University of Rochester, and Yale. Research Interests: Functional MRI (fMRI) advancements, calibrated fMRI for quantitative neural activity, BIRDS molecular imaging (for pH/temperature), and applications in neurodegenerative diseases (e.g., Alzheimer’s) and oncology. Current projects include pH biosensor development, tumor response monitoring, and neuropil density prediction via AI. Awards: Melvin H. Knisely Award, Niels Lassen Award, Lundbeck Visiting Professorship, and fellowships in AIMBE, ARBR, and Sigma Xi. Recently appointed Head of Trumbull College at Yale. Grants: Continuous NIH support across 7 institutes; active projects in molecular imaging, stroke models, and neurovascular coupling. Labs/Teams: MRRC (mrrc.yale.edu), QNMR (qnmr.yale.edu), collaborating with interdisciplinary teams in physics, engineering, and biology.

• Neuroscience
• Neurophysiology
• Biophysics
• +3 more

Dejan Zecevic is a Senior Research Scientist at the Department of Cellular and Molecular Physiology, Yale University School of Medicine. He holds a PhD in Biophysics from the University of Belgrade (1981) and trained under Dr. Lawrence Cohen, a pioneer of voltage-sensitive dye recording. His research focuses on intracellular voltage-sensitive dye imaging, a cutting-edge technology for studying electrical signaling in axons, dendrites, and dendritic spines. Key research interests include action potentials, synaptic integration, and membrane potential dynamics in neuronal structures. Education: PhD in Biophysics, University of Belgrade, Serbia (1981) Research Interests: Zecevic’s work centers on understanding electrophysiological properties of dendritic spines and axons using advanced imaging techniques. He developed voltage-sensitive dye methods to visualize submillisecond membrane potential changes, enabling studies of synaptic signal integration and action potential propagation. His contributions include insights into spine head electrical coupling, axonal conduction mechanisms, and stochastic aspects of dendritic signaling. Key Research Trends: Recent publications highlight his focus on holographic illumination for spine imaging, stochastic backpropagation in dendrites, and leak-resistant axonal conduction. Techniques like computer-generated holography and combined optical methods (voltage + calcium imaging) are central to his work, advancing neurophotonics and systems neuroscience. Labs/Teams: Zecevic collaborates with the Yale Neuroscience community, particularly within the Cellular & Molecular Physiology department. His lab integrates biophysics, optics, and electrophysiology to explore fundamental neuronal mechanisms.

Gail A. CornwallView profile

Professor

• Biological Amyloids
• Reproductive Biology
• Neurodegeneration
• +4 more

Gail A. Cornwall, Ph.D., is a Professor in the Department of Cell Biology and Biochemistry at the Texas Tech University Health Sciences Center School of Medicine. Her research bridges reproductive biology, neuroscience, and structural biochemistry, focusing on the dual roles of biological amyloids in physiological functions and disease mechanisms. Education: Ph.D. in Reproductive Biology, Johns Hopkins Bloomberg School of Public Health Dr. Cornwall's pioneering work centers on functional amyloids—protein aggregates that perform critical biological roles rather than causing pathology. Her lab investigates three interconnected research pillars: the host defense functions of amyloid matrices in the reproductive tract, the structural mechanisms of functional amyloid assembly, and the potential role of sperm amyloids as epigenetic carriers of transgenerational disease. She discovered that the epididymal lumen contains a functional amyloid matrix that traps or kills bacteria depending on pathogen virulence, functioning as a mammalian counterpart to bacterial biofilms. Concurrently, her team explores how similar amyloid structures in the brain may regulate synaptic plasticity, and how environmental toxins induce transmissible amyloid formations in sperm that correlate with inherited disease phenotypes. Analysis of Dr. Cornwall's 15 most recent publications (2023-2012) reveals a cohesive trajectory examining amyloid plasticity across biological systems. Her work consistently integrates structural biology (X-ray crystallography, NMR spectroscopy), transgenic models, and translational approaches to demonstrate how functional amyloids provide evolutionary advantages in host defense while maintaining the structural versatility to contribute to neurodegenerative diseases when dysregulated. Dr. Cornwall leads a multidisciplinary laboratory employing biochemical, cell biological, and biophysical methodologies—including recombinant protein systems, gene knockout mouse models, and advanced imaging—to study amyloid dynamics. Her team maintains active collaborations with structural biologists (R. Bryan Sutton), NMR spectroscopists (Michael P. Latham, Benjamin J. Wylie), and reproductive physiologists to dissect amyloid assembly mechanisms at atomic resolution. Information regarding Dr. Cornwall's student advising roles and specific research grants was not provided in the source materials.

Patricia Chia-Ying LiawView profile

Professor

• Sepsis research
• Coagulation disorders
• Immunothrombosis
• +7 more

Patricia Chia-Ying Liaw is a Professor of Medicine at McMaster University's Michael G. DeGroote School of Medicine. She serves as an Instructor for MEDSCI 733: Vascular Diseases, Haemostasis and Thrombosis II and previously taught HTHSCI 2K03: Inquiry II: Cell Biology. Her academic career spans over three decades with continuous scholarly activity from 1992 to present. Dr. Liaw's primary research focuses on the intersection of sepsis, coagulation disorders, and immunothrombosis. Her work investigates how cell-free DNA, histones, and other damage-associated molecular patterns contribute to coagulopathy in sepsis. She has pioneered research on the protein C pathway, heparin mechanisms, and microfluidic diagnostic devices for sepsis prognosis. Her laboratory studies employ murine models of sepsis to examine therapeutic interventions including DNase and heparin variants. Analysis of her 15 most recent publications (2022-2025) reveals a consistent focus on sepsis pathophysiology, with particular emphasis on sex differences in treatment response, age-related variations in host response, and development of novel diagnostic approaches. Her work bridges basic science with clinical applications, as evidenced by her participation in developing clinical consensus statements for managing antithrombotic therapy in infected patients. Dr. Liaw has made significant contributions to understanding how extracellular DNA and histones drive immunothrombosis in sepsis, with implications for therapeutic interventions targeting these pathways. Her research demonstrates strong translational potential with multiple studies examining practical diagnostic devices and treatment protocols. Her scholarly impact is substantial, with numerous publications cited across various platforms including news outlets, social media, and clinical guideline sources. Many of her papers have been referenced in patents, Wikipedia pages, and clinical practice guidelines, demonstrating the real-world impact of her work.

Karl Alexander DeisserothView profile

Professor

• Optogenetics
• Hydrogel-Tissue Chemistry
• Neural Circuit Function
• +5 more

Karl Deisseroth is the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University, where he leads a research laboratory focused on developing innovative technologies for neuroscience. He is also an Investigator with the Howard Hughes Medical Institute (HHMI) and serves as an attending physician at Stanford Hospital and Clinics. Deisseroth earned his A.B. in Biochemical Sciences from Harvard University in 1992, followed by an M.D. and Ph.D. in Neuroscience from Stanford University in 1998. He completed his medical internship and psychiatry residency at Stanford University School of Medicine. Deisseroth is renowned for pioneering two revolutionary neurotechnologies: optogenetics, which uses light to control specific neurons, and hydrogel-tissue chemistry (including CLARITY and STARmap), which makes biological tissues transparent for detailed examination. His research integrates these technologies to study neural circuit function in both healthy and diseased states, with particular emphasis on understanding the neural basis of psychiatric disorders. His work spans multiple disciplines including neuroscience, bioengineering, and psychiatry, with applications in understanding depression, anxiety, addiction, and other neurological conditions. Analysis of his recent publications reveals a continued focus on advancing both optogenetics and hydrogel-tissue chemistry technologies while applying them to increasingly complex questions in neural circuit function. His work has evolved from foundational technology development to sophisticated applications examining causal relationships in neural circuits underlying behavior and disease. National Academy of Medicine (2010) National Academy of Sciences (2012) National Academy of Engineering (2019) Breakthrough Prize in Life Sciences (2016) Kyoto Prize (2018) Albert Lasker Award for Basic Medical Research (2021) Japan Prize (2023) As a mentor, Deisseroth has guided numerous students and postdoctoral fellows who have gone on to establish their own successful research programs. His laboratory has received substantial funding from the NIH, HHMI, and various private foundations to support its innovative work at the intersection of engineering, neuroscience, and psychiatry. The Deisseroth Lab at Stanford maintains a strong emphasis on interdisciplinary collaboration, bringing together experts from diverse fields to tackle complex problems in brain science. The Deisseroth Lab operates as a highly collaborative environment where engineers, neuroscientists, and clinicians work together to develop and apply cutting-edge technologies. The lab has established numerous resources for the scientific community, including detailed protocols for optogenetics and tissue-clearing techniques, fostering widespread adoption of these methods across neuroscience research worldwide.

Julian D. LangerView profile

Researcher

• Mass Spectrometry
• Structural Biology
• Proteomics
• +5 more

Dr. Julian D. Langer serves as Group Leader and Head of Mass Spectrometry at the Max Planck Institute of Biophysics and Max Planck Institute for Brain Research in Frankfurt. His laboratory specializes in developing advanced mass spectrometry workflows and methods to address complex questions in structural biology, molecular neurobiology, and membrane protein research. Funded by both Max Planck Institutes, his lab operates eight state-of-the-art instruments from Bruker, Thermo, and Waters coupled to nano-UPLCs and analytical UPLCs. Dr. Langer's research focuses on three primary areas: direct sequencing of membrane protein complexes, hydrogen/deuterium exchange mass spectrometry (HDX-MS) for studying membrane protein dynamics, and proteome profiling in neuronal systems. His group has made significant contributions to identifying novel subunits in membrane protein complexes, characterizing ligand binding sites, and monitoring proteome remodeling in homeostatic synaptic plasticity. He is particularly known for developing specialized MALDI-TOF/TOF techniques that allow acquisition of information-rich PSD MS/MS spectra up to m/z 9000. His recent work demonstrates significant trends toward neuroproteomics and small protein discovery , with numerous publications on synaptic proteome mapping, neuronal ribosome dynamics, and detection of novel small proteins in prokaryotes. His research bridges structural biology, neurobiology, and analytical chemistry, with applications spanning from basic membrane protein mechanisms to neurological disorders. Dr. Langer actively collaborates with numerous research groups and is a member of DFG's SPP 2002 (Small proteins in prokaryotes) and BMBF's MOEL-SOEL program. He has developed specialized methodologies including BONCAT technology for proteome turnover studies and workflows for cell-type specific proteome analysis from living animals. His laboratory maintains strong connections with instrument vendors and has successfully extended HDX-MS techniques to large membrane protein complexes. Current research directions include investigating protein synthesis in neuronal processes, characterizing molecular components in specialized cellular systems like Sepia chromatophores, and developing next-generation mass spectrometry approaches for biomolecular analysis.

Hari ArthanariView profile

Associate Professor

• Structural Biology
• Biochemistry
• Biophysics
• +5 more

Hari Arthanari is an Associate Professor in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School . His research focuses on protein-protein interactions and transcriptional Regulation in disease contexts, utilizing NMR spectroscopy , biophysical assays , and cell-based models . He operates the Arthanari Laboratory at Dana-Farber Cancer Institute, with a lab size of 5-10 members. Develops novel NMR methods for fragment screening and metabolite analysis Investigates transcriptional condensates and translation machinery dysregulation in cancer Applies integrative structural biology to therapeutic target discovery Research trends in his publications highlight therapeutic targeting of protein interactions across diverse diseases including cancer and viral infections . His work spans method development for NMR experiments, metabolomics marker identification , and structural characterization of both viral and human proteins. Articles frequently employ techniques like fluorine NMR , 15N TROSY experiments , and computational screening for drug candidate discovery. Scientific awards or formal recognition were not explicitly mentioned in the provided texts. His lab's publications emphasize collaborative multi-institute research and open-source drug discovery platforms , though no specific student advising or grant details were extracted. The Arthanari Lab (website: artlab.dana-farber.org) maintains focus on structural and functional characterization of proteins involved in disease mechanisms, particularly through NMR-derived metabolomics data and protein-ligand interaction identification .

• Alzheimer’s Disease
• Neuroimaging
• Geriatric Psychiatry
• +4 more

Adam Mecca, M.D., Ph.D., is an Associate Professor of Psychiatry and Associate Director of the Yale Alzheimer’s Disease Research Unit at Yale School of Medicine. He specializes in geriatric psychiatry with a focus on memory disorders, particularly Alzheimer’s disease and dementia. His research integrates neuroimaging techniques, such as PET and MRI, to study synaptic density and neurobiological mechanisms of neurodegenerative diseases. He leads clinical trials investigating potential therapies and has pioneered novel imaging methods, including a PET technique to measure synaptic loss in Alzheimer’s patients. Dr. Mecca holds academic affiliations with the Dorothy Adler Geriatric Assessment Center, Alzheimer’s Disease Research Center (ADRC), and the Center for Brain & Mind Health. Education: B.S. in Chemistry and Microbiology, University of Florida (2005) M.D.-Ph.D. from University of Florida College of Medicine (2012), specializing in Physiology and Pharmacology Residency in Psychiatry and Fellowship in Geriatric Psychiatry at Yale University Research Focus: Dr. Mecca’s work centers on Alzheimer’s disease, synaptic dysfunction, and translational neuroimaging. Key areas include: Developing SV2A PET tracers ([11C]UCB-J) to quantify synaptic density Linking cognitive decline to neuroimaging biomarkers Evaluating hearing loss’s impact on Alzheimer’s progression Assessing disparities in dementia diagnosis among language groups Publications & Grants: His 60+ peer-reviewed articles emphasize synaptic imaging, biomarker discovery, and clinical trial design. Notable grants include studies on CT1812’s synaptic effects and Alzheimer’s proteomic signatures. Collaborations span Yale’s neuroscience teams and international AD consortia. Labs/Teams: He directs the Yale Alzheimer’s Disease Research Unit, leading multidisciplinary teams in imaging, clinical trials, and basic science. The lab actively engages in NIH-funded projects and industry partnerships.

Joseph RossView profile

Research Fellow

• Microbiology
• Mycology
• Entomology
• +3 more

Joseph Ross is a Research Fellow in the Keyhani lab at the Department of Biological Sciences, University of Illinois at Chicago. His research focuses on fungal symbiosis, entomopathogens, and microbial interactions with insects, particularly in ambrosia beetles and mosquitoes. He explores host-microbe relationships using advanced techniques like cell cytometry and metabolic profiling. Key areas of investigation include fungal colonization mechanisms in mycangia, viral-fungal co-infections in arthropods, and the ecological impacts of invasive fungal pathogens. Ross also contributes to studies on neurobehavioral therapies for Gulf War Illness using pharmacological agents like oleoylethanolamide. His work bridges microbiology, entomology, and molecular biology, addressing both ecological and biomedical questions through interdisciplinary approaches.

Bernhard WünschView profile

Professor

• Medicinal Chemistry
• Sigma Receptor Ligands
• PET Tracers
• +2 more

Prof. Bernhard Wünsch is a Professor at the Institute of Pharmaceutical and Medicinal Chemistry at the University of Münster. His research focuses on developing novel ligands for sigma receptors and ion channels, with particular emphasis on creating PET tracers and fluorescent probes for neurological imaging. His work bridges medicinal chemistry and neuropharmacology to develop tools for studying brain disorders. Research Focus: Three primary research streams include: 1) Design of sigma receptor ligands for PET imaging of neurological disorders, 2) Development of potassium channel modulators for cancer and pain research, and 3) Creation of fluorescent probes for ion channel visualization. His laboratory employs advanced synthetic chemistry techniques combined with pharmacological validation. Methodological Approach: Publications demonstrate sophisticated organic synthesis of spirocyclic compounds and fluorinated molecules, rigorous receptor binding assays, and translational applications in oncology and neuroscience. Recent work emphasizes enantioselective synthesis and structure-activity relationship studies. Collaborations: Partners with imaging specialists and neurobiologists to validate probes in disease models. Research has applications in Alzheimer's disease, cancer diagnostics, and neuropathic pain management.

Michael BrechtView profile

Researcher

• Neuroscience
• Computational Neuroscience
• Neural Circuits
• +1 more

Michael Brecht is a researcher at the Bernstein Center for Computational Neuroscience , affiliated with Humboldt University Berlin . His work focuses on structure-function relationships in the nervous system , particularly in mammalian brain cells. Research Interests: Decoding neural circuits in the medial entorhinal cortex Linking brain cell structure to functional roles Computational neuroscience approaches to neural microcircuit analysis Scientific Contributions: His 2019 study with Andrea Burgalossi on Microcircuits of functionally identified neurons in the rat medial entorhinal cortex represents a key finding in understanding how specific neurons contribute to brain function. This work aligns with broader trends in computational neuroscience exploring neural architecture and functionality.

• Social determinants of health
• Cardiovascular health disparities
• Nutrition epidemiology
• +9 more

Dr. Carol Oladele serves as Assistant Professor in the Section of General Internal Medicine at Yale School of Medicine and Director of Research at the Equity Research and Innovation Center (ERIC). She maintains a secondary appointment as Assistant Professor in Chronic Disease Epidemiology and is affiliated with the Yale Institute for Global Health. Her work bridges clinical medicine, epidemiology, and health equity research with a focus on addressing cardiovascular health disparities among racial/ethnic and immigrant populations through evidence-based interventions and policy recommendations. Dr. Oladele's educational background includes: PhD in Epidemiology from University of South Florida (2011) MPH in Health Education from University of South Florida (2001) BS in Health Education from Florida State University (1998) Her research program focuses on social determinants of cardiovascular health disparities, with particular emphasis on nutrition, healthcare quality, food environments, and built environments. She has developed specialized dietary assessment methodologies for African descent populations, addressing critical gaps in nutritional epidemiology. Current investigations examine how food insecurity and ultra-processed food consumption contribute to disparities in hypertension incidence and control, particularly in the Eastern Caribbean region through the Eastern Caribbean Health Outcomes Research Network (ECHORN). Her work aims to generate evidence that can inform health policies and interventions to improve cardiovascular outcomes among vulnerable populations globally. Analysis of Dr. Oladele's recent publications reveals a consistent focus on health disparities related to cardiovascular disease, nutrition, and social determinants of health. Her research spans multiple populations with significant attention to Caribbean communities, investigating how structural factors like food insecurity and access to healthy foods impact chronic disease outcomes. Methodologically, she employs epidemiological cohort studies, dietary assessment tools, and analyses of social determinants of health, contributing valuable insights to the field of health equity. Dr. Oladele has received recognition for her contributions to health disparities research: Extramural Loan Repayment Program for Health Disparities Research from the National Institutes of Health (2021) As Director of Research at ERIC, Dr. Oladele leads initiatives focused on advancing health equity through interdisciplinary collaboration. She actively participates in peer review for the Patient Centered Outcomes Research Institute and the National Institutes of Health. Her collaborative network includes Marcella Nunez-Smith (11 publications), Josefa L. Martinez, Rafael Pérez-Escamilla, and Saria Hassan, reflecting her commitment to addressing health disparities through multidisciplinary approaches. Dr. Oladele's work with ECHORN demonstrates her dedication to building regional capacity for noncommunicable disease control in disaster-prone Caribbean settings. She contributes significantly to Yale's global health initiatives through her affiliation with the Yale Institute for Global Health and presents her research at major conferences including the American Public Health Association Annual Meeting and the American Heart Association EPI/Lifestyle Scientific Sessions.

Seungil KimView profile

Assistant Professor

• Biomedical Polymer Engineering
• Biomaterials Science
• Drug Delivery Systems
• +4 more

Dr. Seungil Kim is an Assistant Professor of Biomedical Engineering at Mississippi State University's Department of Agricultural and Biological Engineering. His research focuses on biomedical polymer engineering, particularly in designing sustainable, biocompatible, and stimuli-responsive polymers for applications in vascular repair, embolization systems, and drug delivery. He holds a Ph.D. in Biomedical Engineering from the University of Manitoba and completed postdoctoral training at the University of Pittsburgh's McGowan Institute for Regenerative Medicine. Dr. Kim's work emphasizes structure-property-function relationships in biomaterials, including bioresorbable embolization coils, injectable hydrogels for cerebral aneurysms, and wireless drug delivery systems. He has received grants from the Brain Aneurysm Foundation (2022, 2023) and served on organizing committees for the Korean-American Scientists and Engineers Association (KSEA) SEED workshops (2023–2024). His leadership roles include NIH Early Career Reviewer (2023) and Guest Editor for Coatings (2022). His lab develops innovative biomaterials for cardiovascular and neural applications, with a focus on translating research into clinical solutions. Current projects include biodegradable heart valve frames, shape-memory devices activated by ultrasound, and anti-thrombotic coatings for medical devices. Dr. Kim seeks motivated graduate students and long-term undergraduate researchers to advance these areas.